Cardiac Function and Metabolism in Young Adults Born Premature (PET-MRI)
- Conditions
- Infant,Premature
- Interventions
- Procedure: Pulmonary Function TestingProcedure: ElectrocardiogramProcedure: Positron Emission TomographyProcedure: Magnetic Resonance Imaging
- Registration Number
- NCT03245723
- Lead Sponsor
- University of Wisconsin, Madison
- Brief Summary
The purpose of this research is to determine the effect of premature birth on later heart function and metabolism.
- Detailed Description
The purpose of this study is to determine the effects of premature birth on cardiac function, cardiac metabolism, and oxidative stress in a cohort of young adults born prematurely using cardiac positron emission tomography/magnetic resonance imaging and mitochondrial respiration studies.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 52
- National Lung Project Cohort only- birth weight <1500g and a gestational age <36 weeks
- Adults born preterm (Non-National Lung Project) only- gestational age ≤32 weeks OR birth weight ≤ 3lbs 5oz
- Healthy Controls only- No personal history of known cardiovascular or pulmonary disease
- Metabolic Disorders that would affect Fludeoxyglucose uptake
- Contraindications to positron emission tomography and/or magnetic resonance imaging
- Pregnancy, if a female of child-bearing potential
- A personal history of Type I or Type II diabetes
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Preterm Positron Emission Tomography Participants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Preterm Pulmonary Function Testing Participants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Preterm Magnetic Resonance Imaging Participants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Term - Healthy Controls Pulmonary Function Testing Healthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Preterm Electrocardiogram Participants born premature either registered on the National Lung Project (currently in their late twenties) or not registered on the National Lung Project Cohort (current age ranges 18-35 years). All the participants in this group will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Term - Healthy Controls Magnetic Resonance Imaging Healthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Term - Healthy Controls Electrocardiogram Healthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging. Term - Healthy Controls Positron Emission Tomography Healthy individuals that were not born premature. Individuals are ages 18-35. Subjects will undergo Pulmonary Function Testing, Electrocardiogram, Positron Emission Tomography, and Magnetic Resonance Imaging.
- Primary Outcome Measures
Name Time Method Cardiac Glucose Uptake During Normoxic Rest (µg/Min) Visit 1 (1 day) Cardiac glucose uptake will be measured via 18F-fluorodeoxyglucose (FDG) PET-MRI.
Change in Glucose Uptake From Normoxia to Hypoxia (µg/Min) Visit 1 (1 day) Cardiac glucose uptake will be measured via 18F-fluorodeoxyglucose (FDG) PET-MRI.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
UW Madison
🇺🇸Madison, Wisconsin, United States